Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
XenoPort, Inc. (NQ: XNPT)
5.430 USD  +0.270 (+5.23%)
Official Closing Price  /  Updated: 4:00 PM EDT, Jun 18, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about XenoPort, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
XenoPort Shares Down 23.2% Since SmarTrend's Sell Call (XNPT)
June 17, 2013
from Comtex SmarTrend® News Briefs
Mid-Day Update: Benzinga's Top Downgrades
June 11, 2013
Analysts at Benchmark downgraded Moody's (NYSE: MCO ) from Buy to Hold. The target price for Moody's has been raised from $60 to $71. Moody's shares are currently trading at $64.01, down 1.52 percent... Read More
category Benzinga , Benchmark , Morgan Stanley , and 8 more.
from Latest Articles from Benzinga.com
XenoPort to Present at the Wells Fargo Securities Healthcare Conference
June 11, 2013
from Business Wire News Releases
UPDATE: Morgan Stanley Downgrades XenoPort on Recent Failures
June 11, 2013
In a report published on Tuesday, Morgan Stanley analyst David Friedman downgraded XenoPort (NASDAQ: XNPT ) from Equal-Weight to Underweight and lowered the price target on the company from $3 to $2.... Read More
category Benzinga , Morgan Stanley , Downgrades , and 4 more.
from Latest Articles from Benzinga.com
Morgan Stanley Downgrades XenoPort (XNPT) to Underweight
June 11, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8404877 for the full story. Read More
from StreetInsider.com News Articles
XenoPort Has Returned 21.5% Since SmarTrend Recommendation (XNPT)
June 07, 2013
from Comtex SmarTrend® News Briefs
XenoPort Announces New Employment Inducement Awards
June 07, 2013
from Business Wire News Releases
Oversold Conditions For XenoPort Inc (XNPT)
June 06, 2013
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... Read More
category Stocks
from Market News Video
Downtrend Call Working As XenoPort Stock Falls 17.2% (XNPT)
May 31, 2013
from Comtex SmarTrend® News Briefs
Bio-Wire Equity Surveillance – Closing Bell 5/30/2013
May 30, 2013
Thursday, May 30th, 2013 Overview It was a very bullish day, particularly for the biotech sector. Large pharmaceutical companies (>$10 B) moved an average of +.6%, while medium sized companies moved... Read More
category AMRN , SRPT , CLSN , and 5 more.
from Bio-Wire.Com
Downtrend Call Working As XenoPort Stock Falls 18.8% (XNPT)
May 24, 2013
from Comtex SmarTrend® News Briefs
UPDATE: Deutsche Bank Reiterates Buy, Lowers PT on XenoPort on Disappointing Results
May 21, 2013
In a report published Tuesday, Deutsche Bank analyst Greg Poole reiterated a Buy rating on XenoPort (NASDAQ: XNPT ), but lowered the price target from $12.00 to $9.00. In the report, Deutsche Bank... Read More
category Deutsche Bank , Benzinga , XNPT , and 3 more.
from Latest Articles from Benzinga.com
Free Research Reports on HERO, IQNT, LDK and XNPT Issued by the Bedford Report
May 21, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
Stocks to Watch: National Bank of Greece (ADR)(NYSE:NBG), Team, Inc. (NYSE:TISI), XenoPort, Alaska Air Group
May 21, 2013
Austin, TX -- (SBWIRE) -- 05/21/2013 -- Jackpotpennystocks.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues... Read More
from SBWire - Latest Press Releases
NASDAQ Decliners Watch List: Xenoport, Inc. (NASDAQ:XNPT), Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), and the Spectranetics Corporation (NASDAQ:SPNC) Added to Growing Stock Report's NASDAQ Decliner
May 21, 2013
New York, NY -- (SBWIRE) -- 05/21/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Xenoport, Inc. (NASDAQ:XNPT), Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), and The... Read More
from SBWire - Latest Press Releases
Downgrade Alert for XenoPort (XNPT)
May 21, 2013
from Comtex SmarTrend® News Briefs
UPDATE: Wedbush Downgrades XenoPort as Arbaclofen Fails in Phase III of MS Spasticity Trial
May 20, 2013
In a report published on Monday, Wedbush analyst Gregory R. Wade downgraded XenoPort (NASDAQ: XNPT ) from Outperform to Neutral and lowered the price target for the company from $16 to $6. In the... Read More
category Benzinga , Downgrades , Wedbush , and 4 more.
from Latest Articles from Benzinga.com
Bio-Wire Equity Surveillance – Closing Bell 5/20/2013
May 20, 2013
Medium and large sized pharmaceutical companies were down by an average of .3-.6% at the closing bell Jumps by % Gain and Mkt Cap Change Biolife Solutions (OTC: BLFS) +34% on spike in trading activity... Read More
category RPTP , ACAD , MDXG , and 15 more.
from Bio-Wire.Com
Today's Market View: AFFY, OSIS, XNPT, AU
May 20, 2013
New York, NY -- (SBWIRE) -- 05/20/2013 -- Affymax, Inc.(NASDAQ:AFFY) shares dropped 6.76% to $1.24. In its Form 10-Q filed with the SEC, Affymax on May 9 said it has experienced significant operating... Read More
from SBWire - Latest Press Releases
Wedbush Downgrades XenoPort (XNPT) to Neutral
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8354429 for the full story. Read More
from StreetInsider.com News Articles
Unusual 11 Mid-Day Movers 05/20: (AQ) (MEAD) (RSOL) Higher; (NBG) (TISI) (IEC) Lower
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8354406 for the full story. Read More
from StreetInsider.com News Articles
Xenoport, Inc. (NASDAQ:XNPT), Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), and the Spectranetics Corporation (NASDAQ:SPNC) Added to Equity Profile Report's NASDAQ Decliners Watch List.
May 20, 2013
Wilmington, DE -- (SBWIRE) -- 05/20/2013 -- Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding Xenoport, Inc. (NASDAQ:XNPT), Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), and... Read More
from SBWire - Latest Press Releases
XenoPort Trading Lower on Heavy Volume, Inline With Overall Trend (XNPT)
May 20, 2013
from Comtex SmarTrend® News Briefs
Mixed Open After Records Last Week
May 20, 2013
The markets opened mixed with the Dow slipping 11 points to 15,342 while Nasdaq added 3 points to 3501 as investors took a breather after another record close last week. Read More
category Market News
from MarketMinute.com Market Updates
StreetInsider.com Pre-Open Movers 5/20: (AQ) (WBSN) (SCTY) Higher; (XNPT) (KMX) (SNV) Lower (more...)
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8353760 for the full story. Read More
from StreetInsider.com News Articles
XenoPort (XNPT) Arbaclofen Placarbil Phase 3 Misses Endpoints
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8353282 for the full story. Read More
from StreetInsider.com News Articles
UPDATE 1-XenoPort to drop multiple sclerosis drug after trial failure
May 20, 2013
May 20 (Reuters) - XenoPort Inc said it will stop developing its experimental multiple sclerosis treatment after data from a late-stage trial showed the drug did not improve patients' condition... Read More
category companyNews
from Reuters: Company News
XenoPort Reports Unsuccesful Phase 3 Trial Results of Arbaclofen Placarbil for Spasticity in MS Patients
May 20, 2013
XenoPort, Inc. (NSDAQ: XNPT) announced today top-line results from its pivotal Phase 3 clinical trial of arbaclofen placarbil (AP) for the treatment of patients with spasticity due to multiple... Read More
category Contracts , Management , Benzinga , and 4 more.
from Latest Articles from Benzinga.com
XenoPort to drop multiple sclerosis drug after trial failure
May 20, 2013
May 20 (Reuters) - XenoPort Inc said it will stop developing its experimental multiple sclerosis treatment after data from a late-stage trial showed the drug did not improve patients' condition... Read More
category companyNews
from Reuters: Company News
XenoPort Reports Top-Line Results of Phase 3 Trial of Arbaclofen Placarbil for Spasticity in Multiple Sclerosis Patients
May 20, 2013
from Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here